Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease.

Centanni S, Di Marco F.

Expert Opin Pharmacother. 2005 Nov;6(14):2525-34. Review. Erratum in: Expert Opin Pharmacother. 2005 Dec;6(15):2779.

PMID:
16259583
2.

Budesonide/formoterol: in chronic obstructive pulmonary disease.

Reynolds NA, Perry CM, Keating GM.

Drugs. 2004;64(4):431-41; discussion 433-4. Review.

PMID:
14969576
3.

Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

Nannini L, Cates CJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2004;(3):CD003794. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD003794.

PMID:
15266502
5.

Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

Nannini L, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2003;(4):CD003794. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003794.

PMID:
14583994
6.
7.

Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.

Cazzola M.

Pulm Pharmacol Ther. 2006;19(2):79-89. Epub 2005 Jun 16. Review.

PMID:
15964228
8.

Budesonide/formoterol Turbuhaler®: a review of its use in chronic obstructive pulmonary disease.

Scott LJ.

Drugs. 2012 Feb 12;72(3):395-414. doi: 10.2165/11208460-000000000-00000. Review.

PMID:
22316354
9.
10.

Budesonide/formoterol pressurized metered-dose inhaler: in chronic obstructive pulmonary disease.

Lyseng-Williamson KA.

Drugs. 2009 Jul 30;69(11):1459-70. doi: 10.2165/00003495-200969110-00005. Review.

PMID:
19634924
11.

Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.

Löfdahl CG, Ericsson A, Svensson K, Andreasson E.

Pharmacoeconomics. 2005;23(4):365-75.

PMID:
15853436
12.

Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.

Sharafkhaneh A, Southard JG, Goldman M, Uryniak T, Martin UJ.

Respir Med. 2012 Feb;106(2):257-68. doi: 10.1016/j.rmed.2011.07.020. Epub 2011 Oct 26.

13.

Budesonide/formoterol combination in COPD: a US perspective.

Sharafkhaneh A, Mattewal AS, Abraham VM, Dronavalli G, Hanania NA.

Int J Chron Obstruct Pulmon Dis. 2010 Oct 5;5:357-66. doi: 10.2147/COPD.S4215. Review.

14.

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD.

Cazzola M, Noschese P, De Michele F, D'Amato G, Matera MG.

Respir Med. 2006 Feb;100(2):212-7. Epub 2005 Jun 3.

15.

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study.

Ställberg B, Selroos O, Vogelmeier C, Andersson E, Ekström T, Larsson K.

Respir Res. 2009 Feb 19;10:11. doi: 10.1186/1465-9921-10-11.

16.

Efficacy and safety of budesonide/formoterol via a dry powder inhaler in Chinese patients with chronic obstructive pulmonary disease.

Zhong N, Zheng J, Wen F, Yang L, Chen P, Xiu Q, Yao W, Sun T, Zhao Z, Shen H, Shi Y, Lin J, Li Q.

Curr Med Res Opin. 2012 Feb;28(2):257-65. doi: 10.1185/03007995.2011.636420. Epub 2012 Jan 20.

PMID:
22046961
17.

Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.

Bathoorn E, Liesker JJ, Postma DS, Boorsma M, Bondesson E, Koëter GH, Kauffman HF, van Oosterhout AJ, Kerstjens HA.

COPD. 2008 Oct;5(5):282-90. doi: 10.1080/15412550802363360.

PMID:
18972276
18.

The use of inhaled formoterol in the treatment of asthma.

Berger WE.

Ann Allergy Asthma Immunol. 2006 Jul;97(1):24-33. Review. Erratum in: Ann Allergy Asthma Immunol. 2006 Oct;97(4):562. Dosage error in article text.

PMID:
16892777
19.

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.

Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H.

Eur Respir J. 2003 Dec;22(6):912-9. Erratum in: Eur Respir J. 2004 Dec;24(6):1075.

20.

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.

Nannini LJ, Cates CJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD006829. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD006829.

PMID:
17943918
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk